
    
      The purpose of this study is to collect on-label safety and efficacy data where InQu Bone
      Graft Extender is applied to transforaminal lumbar interbody fusion (TLIF) and posterior
      lumbar interbody fusion (PLIF) at multiple clinical sites.

      Adverse events, time to fusion and Patient Reported Outcomes(PROs) will be recorded through
      12 months follow-up.
    
  